NZ182630A - Substituted n-methylene dervatives of thienamycin and pharmaceutical compositions - Google Patents
Substituted n-methylene dervatives of thienamycin and pharmaceutical compositionsInfo
- Publication number
- NZ182630A NZ182630A NZ182630A NZ18263076A NZ182630A NZ 182630 A NZ182630 A NZ 182630A NZ 182630 A NZ182630 A NZ 182630A NZ 18263076 A NZ18263076 A NZ 18263076A NZ 182630 A NZ182630 A NZ 182630A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dervatives
- thienamycin
- methylene
- substituted
- pharmaceutical compositions
- Prior art date
Links
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 title 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63429675A | 1975-11-21 | 1975-11-21 | |
| US67626176A | 1976-04-12 | 1976-04-12 | |
| US73365476A | 1976-10-18 | 1976-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ182630A true NZ182630A (en) | 1979-07-11 |
Family
ID=27417545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ182630A NZ182630A (en) | 1975-11-21 | 1976-11-15 | Substituted n-methylene dervatives of thienamycin and pharmaceutical compositions |
Country Status (27)
| Country | Link |
|---|---|
| AT (1) | AT358168B (de) |
| AU (1) | AU512383B2 (de) |
| BG (1) | BG34037A3 (de) |
| CA (1) | CA1083577A (de) |
| CH (2) | CH632510A5 (de) |
| DD (1) | DD127742A5 (de) |
| DE (1) | DE2652679A1 (de) |
| DK (1) | DK157401C (de) |
| EG (1) | EG12261A (de) |
| ES (1) | ES453501A1 (de) |
| FI (1) | FI62306C (de) |
| FR (1) | FR2332012A1 (de) |
| GB (1) | GB1570990A (de) |
| GR (1) | GR62072B (de) |
| HK (1) | HK29683A (de) |
| HU (1) | HU180865B (de) |
| IE (1) | IE44433B1 (de) |
| IL (1) | IL50911A (de) |
| KE (1) | KE3286A (de) |
| NL (1) | NL189297C (de) |
| NO (1) | NO153298C (de) |
| NZ (1) | NZ182630A (de) |
| PH (1) | PH16714A (de) |
| PL (1) | PL110937B1 (de) |
| PT (1) | PT65865B (de) |
| SE (1) | SE427841B (de) |
| SG (1) | SG10983G (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1593524A (en) * | 1976-11-19 | 1981-07-15 | Merck & Co Inc | 1-carba-2-penem-3-carboxylic acids |
| SE436569B (sv) * | 1977-05-05 | 1985-01-07 | Merck & Co Inc | Analogiforfarande for framstellning av tienamycinderivat |
| US4232030A (en) * | 1977-09-15 | 1980-11-04 | Merck & Co., Inc. | Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone |
| DK153486C (da) * | 1978-07-03 | 1988-11-28 | Merck & Co Inc | Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat |
| EP0044170A1 (de) * | 1980-07-11 | 1982-01-20 | Beecham Group Plc | Beta-Lactam-Antibiotika, ihre Herstellung und Verwendung |
| CA2089261A1 (en) * | 1990-08-30 | 1992-03-01 | John F.W. Keana | Substituted amidines having high binding to the sigma receptor and the use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1004670A (en) * | 1963-04-23 | 1965-09-15 | Beecham Res Lab | Penicillins |
| GB1348984A (en) * | 1970-06-16 | 1974-03-27 | Merck & Co Inc | Antibiotics and processes for their production |
| US3950357A (en) * | 1974-11-25 | 1976-04-13 | Merck & Co., Inc. | Antibiotics |
-
1976
- 1976-11-15 IL IL50911A patent/IL50911A/xx unknown
- 1976-11-15 AU AU19647/76A patent/AU512383B2/en not_active Expired
- 1976-11-15 NZ NZ182630A patent/NZ182630A/xx unknown
- 1976-11-18 IE IE2542/76A patent/IE44433B1/en not_active IP Right Cessation
- 1976-11-18 FI FI763308A patent/FI62306C/fi not_active IP Right Cessation
- 1976-11-18 PH PH19142A patent/PH16714A/en unknown
- 1976-11-19 NL NLAANVRAGE7612939,A patent/NL189297C/xx not_active IP Right Cessation
- 1976-11-19 ES ES453501A patent/ES453501A1/es not_active Expired
- 1976-11-19 DK DK523576A patent/DK157401C/da not_active IP Right Cessation
- 1976-11-19 PT PT65865A patent/PT65865B/pt unknown
- 1976-11-19 SE SE7612963A patent/SE427841B/xx not_active IP Right Cessation
- 1976-11-19 HU HU76ME2032A patent/HU180865B/hu unknown
- 1976-11-19 GB GB48240/76A patent/GB1570990A/en not_active Expired
- 1976-11-19 DE DE19762652679 patent/DE2652679A1/de active Granted
- 1976-11-19 FR FR7634882A patent/FR2332012A1/fr active Granted
- 1976-11-19 CA CA266,186A patent/CA1083577A/en not_active Expired
- 1976-11-19 BG BG7634723A patent/BG34037A3/xx unknown
- 1976-11-19 DD DD7600195868A patent/DD127742A5/de unknown
- 1976-11-19 CH CH1462376A patent/CH632510A5/de not_active IP Right Cessation
- 1976-11-19 NO NO763958A patent/NO153298C/no unknown
- 1976-11-19 AT AT863476A patent/AT358168B/de active Protection Beyond IP Right Term
- 1976-11-20 PL PL1976193809A patent/PL110937B1/pl not_active IP Right Cessation
- 1976-11-20 GR GR52223A patent/GR62072B/el unknown
- 1976-11-21 EG EG76723A patent/EG12261A/xx active
-
1980
- 1980-09-26 CH CH725580A patent/CH633800A5/de not_active IP Right Cessation
-
1983
- 1983-03-14 SG SG109/83A patent/SG10983G/en unknown
- 1983-04-08 KE KE3286A patent/KE3286A/xx unknown
- 1983-08-18 HK HK296/83A patent/HK29683A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1524578A (en) | Aminobenzoamide compounds and pharmaceutical compositions containing them | |
| NZ180529A (en) | Erythromyc-9-yl-amine derivatives and pharmaceutical compositions | |
| GB1551275A (en) | Process for the preparation of plasminogen activators and pharmaceutical compositions containing plasminogen activators obtained by the process | |
| ZA763917B (en) | Pharmaceutical compositions and compounds | |
| JPS51146449A (en) | Preparation of novel cromanci compound and pharmaceutical composition | |
| JPS5262273A (en) | Ppoduction of benzisothiazolone and pharmaceutical composition | |
| JPS5268177A (en) | Production of indazole derivatives and pharmaceutical composition containing the same | |
| NZ181503A (en) | Substituted diphenyls-ulphides and pharmaceutical compositions | |
| AU507272B2 (en) | Pharmaceutical compositions and compounds | |
| NZ182591A (en) | 14-substituted-daunorubicins and pharmaceutical compositions | |
| PH12834A (en) | Pharmaceutical compositions containing 1,3-dithiol-2-ylidene derivatives and method of treatment using said composition | |
| NZ182630A (en) | Substituted n-methylene dervatives of thienamycin and pharmaceutical compositions | |
| IL49041A (en) | Propanolamine derivatives their preparation and bacteriostatic compositions containing them | |
| NZ181864A (en) | Noroxymorphones and pharmaceutical compositions | |
| NZ182581A (en) | -amino-ketones and pharmaceutical compositions | |
| NZ182161A (en) | Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions | |
| IL49122A (en) | L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same | |
| JPS5233649A (en) | Compositions of substances and process | |
| NZ181168A (en) | 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates | |
| JPS525799A (en) | Production of indroquinolidine derivative and pharmaceutical composition containing same | |
| NZ181727A (en) | Pyrroline-2-one derivatives and pharmaceutical compositions | |
| JPS5218810A (en) | Complex medical composition of estrogennprostaglangin | |
| NZ181401A (en) | 2-benzopyranone derivatives and pharmaceutical compositions | |
| NZ181146A (en) | Benzocycloheptathiophene derivatives and pharmaceutical compositions | |
| JPS52297A (en) | Production of pyridquinline derivative and pharmaceutical composition containing same |